Skip to main content


U.S. flag
      An official website of the United States government
              Here’s how you know
        Here’s how you knowDot gov**Official websites use .gov**
                 A **.gov** website belongs to an official government organization in the United States.
                  HTTPS**Secure .gov websites use HTTPS**
                 A **lock** (A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. 
  Menu Close
          Enter the terms you wish to search for.
    Search
        








  
  
    

  
      

                                      About HHS
    
                        
                              
      
      
      Programs & Services
    
                        
                              
      
      
      Grants & Contracts
    
                        
                              
      
      
      Laws & Regulations Breadcrumb
    Home
                              About
                              News
                              Fact Sheet: The Biden-Harris Administration Urges Congress to Lower Drug Costs for Americans with Commercial Insurance
 Navigate to:
  News
    
                                    
                                            
            
      
      
      
      Blog
    
                                    
                                            
            
      
      
      
      HHS Live
    
                                    
                                            
            
      
      
      
      Podcasts
    
                                    
                                            
            
      
      
      
      Media Guidelines for HHS EmployeesText resize icon

                    




**FOR IMMEDIATE RELEASE March 11, 2024**

        **Contact:
            HHS Press Office 
              202-690-6343media@hhs.gov**

          Fact Sheet: The Biden-Harris Administration Urges Congress to Lower Drug Costs for Americans with Commercial Insurance
    
    

      President Biden’s prescription drug law, the Inflation Reduction Act, was signed into law on August 16, 2022. This new law provides meaningful financial relief for millions of people with Medicare by expanding benefits, lowering drug costs, and strengthening Medicare for the future.

Thanks to the President’s new lower cost prescription drug law, the lives of Medicare enrollees are changing for the better. The benefits for seniors and people with disabilities include:

A $35/month cap on the cost of each Medicare-covered insulin product;
	Free recommended adult vaccines, such as shingles and RSV, for Medicare Part D enrollees;
	Continued enhanced subsidies for Marketplace plans, reducing the cost of premiums for eligible individuals;
	Rebates to be paid by drug manufacturers to Medicare if they increase their prices for certain drugs at a rate that exceeds the rate of inflation, reducing the costs of some drugs;
	A $2,000 annual cap on out-of-pocket costs in Medicare Part D in 2025; and
	Medicare directly negotiating drug prices with manufacturers.The President’s FY 2025 budget builds on the Inflation Reduction Act and lowers the cost of prescription drugs for even more Americans, including the 189 million Americans under age 65 with private insurance coverage, by proposing to:

**Let Medicare Negotiate More Drug Prices:** Medicare should not be limited to negotiating just 20 drugs or fewer per year. Instead, the President is proposing that Medicare be able to negotiate prices for more drugs that seniors and people with disabilities rely on, including more drugs used to treat heart disease, cancer, and diabetes.
	**Expand Cap on Out-of-Pocket Prescription Drug Costs:** The President is calling on Congress to expand the $2,000 out-of-pocket cap in Medicare Part D that was created in the Inflation Reduction Act to *all private insurance market plans* so that the 189 million Americans under 65 with private insurance have the peace of mind that comes with knowing that they won't have to choose between filling their prescription or putting food on the table.
	**Test Lower Cost-Sharing for High-Value Generic Drugs in Medicare:** The Center for Medicare & Medicaid Innovation is developing a new model to test lower Medicare Part D cost-sharing for certain high-value generic drugs of $2 for a month’s supply. The President is calling on Congress to limit Medicare cost-sharing to $2 for high-value generic drugs for *all Medicare plans*.
	**Expand the Inflation Reduction Act’s Requirement that Drug Companies Pay Rebates When They Increase Prices Faster than Inflation:**Thanks to the President’s prescription drug law, drug manufacturers must now pay rebates to Medicare if prices increase for certain Part B and Part D drugs exceed the rate of inflation. The President is calling on Congress to require those rebates for commercial drug sales. This will further curb prescription drug price inflation for everyone and could reduce health insurance premiums for the millions of Americans with private health insurance coverage.
  

    ###
    Note: All HHS press releases, fact sheets and other news materials are available at https://www.hhs.gov/news.Like HHS on Facebook, follow HHS on Twitter @HHSgov, and sign up for HHS Email Updates.Last revised: March 11, 2024

  
  
  







  Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases

Sign Up







  Subscribe to RSS
    

      Receive latest updates







  Related News Releases
    

      During Second Chance Month, HRSA Takes Policy Action, Releases First-Ever Funding Opportunity for Health Centers to Support Transitions in Care for People Leaving Incarceration
  

HHS, DOJ, and FTC Issue Request for Public Input as Part of Inquiry into Impacts of Corporate Ownership Trend in Health Care
  

HHS Secretary Xavier Becerra Tours New England, Announces $100 Million Investment in Women’s Healthcare Alongside the First Lady







  Related Blog Posts
    

      Upholding Research Integrity at HHS

                    
  


Media Inquiries

For general media inquiries, please contact media@hhs.gov.







  Content created by Assistant Secretary for Public Affairs (ASPA) Content last reviewed March 11, 2024 Back to top
    Contact HHS
    
                        
                                            
      
      
      Careers
    
                        
                                            
      
      
      HHS FAQs
    
                        
                                            
      
      
      Nondiscrimination NoticeHHS Archive
    
                        
                                            
      
      
      Accessibility
    
                        
                                            
      
      
      Privacy Policy
    
                        
                                            
      
      
      Viewers & PlayersBudget/Performance
    
                        
                                            
      
      
      Inspector General
    
                        
                                            
      
      
      Web Site Disclaimers
    
                        
                                            
      
      
      EEO/No Fear ActFOIA
    
                        
                                            
      
      
      The White House
    
                        
                                            
      
      
      USA.gov
    
                        
                                            
      
      
      Vulnerability Disclosure Policy
        Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases.

Sign Up
  HHS Headquarters
          200 Independence Avenue, S.W.
                  Washington, D.C. 20201
                  Toll Free Call Center: 1-877-696-6775​